Notice2026-18586
Citric Acid and Certain Citrate Salts From Canada and India; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 11, 2026
Issuing agencies
International Trade Commission
Abstract
The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-783-784 and 731-TA-1771-1772 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of citric acid and certain citrate salts, provided for in subheadings 2918.14.00, 2918.15.10, 2918.15.50, and 3824.99.93 of the Harmonized Tariff Schedule of the United States, from China that have been preliminarily determined by the Department of Commerce ("Commerce") to be subsidized by the government of China and sold at less-than-fair-value, and by reason of imports of citric acid and certain citrate salts from Canada that have been preliminarily determined by Commerce to be subsidized by the government of Canada but preliminarily determined by Commerce not to be, or not likely to be, sold at less-than-fair-value.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 175 (Friday, September 11, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 175 (Friday, September 11, 2026)]
[Notices]
[Pages 57920-57922]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18586]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-783-784 and 731-TA-1771-1772 (Final)]
Citric Acid and Certain Citrate Salts From Canada and India;
Scheduling of the Final Phase of Countervailing Duty and Antidumping
Duty Investigations
AGENCY: United States International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Commission hereby gives notice of the scheduling of the
final phase of antidumping and countervailing duty investigation Nos.
701-TA-783-784 and 731-TA-1771-1772 (Final) pursuant to the Tariff Act
of 1930 to determine whether an industry in the United States is
materially injured or threatened with material injury, or the
establishment of an industry in the United States is materially
retarded, by reason of imports of citric acid and certain citrate
salts, provided for in subheadings 2918.14.00, 2918.15.10, 2918.15.50,
and 3824.99.93 of the Harmonized Tariff Schedule of the United States,
from China that have been preliminarily determined by the Department of
Commerce (``Commerce'') to be subsidized by the government of China and
sold at less-than-fair-value, and by reason of imports of citric acid
and certain citrate salts from Canada that have been preliminarily
determined by Commerce to be subsidized by the government of Canada but
preliminarily determined by Commerce not to be, or not likely to be,
sold at less-than-fair-value.
DATES: August 26, 2026.
FOR FURTHER INFORMATION CONTACT: Gregory Gutierrez (205-1999), Office
of Investigations, U.S. International Trade Commission, 500 E Street
SW, Washington, DC 20436. Hearing-impaired persons can obtain
information on this matter by contacting the Commission's TDD terminal
on 202-205-1810. Persons with mobility impairments who will need
special assistance in gaining access to the Commission should contact
the Office of the Secretary at 202-205-2000. General information
concerning the Commission may also be obtained by accessing its
internet server (<a href="https://www.usitc.gov">https://www.usitc.gov</a>). The public record for these
investigations may be viewed on the Commission's electronic docket
(EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>.
SUPPLEMENTARY INFORMATION:
Scope.--For purposes of these investigations, Commerce has defined
the subject merchandise as ``all grades and granulation sizes of citric
acid, sodium citrate, and potassium citrate in their unblended forms,
whether dry or in solution, and regardless of packaging type. The scope
also includes blends of citric acid, sodium citrate, and potassium
citrate, as well as blends with other ingredients, such as sugar, where
the unblended form(s) of citric acid, sodium citrate, and potassium
citrate constitute 40 percent or more, by weight, of the blend. The
scope also includes all forms of crude calcium citrate, including
dicalcium citrate monohydrate, and tricalcium citrate tetrahydrate,
which are intermediate products in the production of citric acid,
sodium citrate, and potassium citrate. The scope includes the hydrous
and anhydrous forms of citric acid, the dihydrate and anhydrous forms
of sodium citrate, otherwise known as citric acid sodium salt, and the
monohydrate and monopotassium forms of potassium citrate. Sodium
citrate also includes both trisodium citrate and monosodium citrate
which are also known as citric acid trisodium salt and citric acid
monosodium salt, respectively. The scope includes merchandise matching
the above description that has been processed in a third country,
including by commingling, diluting, introducing or removing additives,
or performing any other processing that would not otherwise remove the
merchandise from the scope of the investigations if performed in the
subject country. The scope also includes merchandise matching the above
description that is commingled or blended with citric acid, sodium
citrate, and potassium citrate from sources not subject to these
investigations. Only the subject component of such commingled products
is covered by the scope of these investigations. The scope does not
include calcium citrate that satisfies the standards set forth in the
United States Pharmacopeia and has been mixed with a functional
excipient, such as dextrose or starch, where the excipient constitutes
at least two percent, by weight, of the product.''
Background.--The final phase of these investigations is being
scheduled
[[Page 57921]]
pursuant to sections 705(b) and 731(b) of the Tariff Act of 1930 (19
U.S.C. 1671d(b) and 1673d(b)), as a result of a negative preliminary
determination by Commerce regarding whether citric acid and certain
citrate salts from Canada are being sold at less than fair value within
the meaning of Sec. 733 of the Act (19 U.S.C. 1673b), and as a result
of affirmative preliminary determinations by Commerce that certain
benefits which constitute subsidies within the meaning of Sec. 703 of
the Act (19 U.S.C. 1671b) are being provided to manufacturers,
producers, or exporters in Canada and India of citric acid and certain
citrate salts, and that such products from India are being sold in the
United States at less than fair value within the meaning of Sec. 733
of the Act (19 U.S.C. 1673b). The investigations were requested in
petitions filed on January 21, 2026, by Archer-Daniels-Midland Company,
Decatur, Illinois; Cargill, International, Wayzata, Minnesota; and
Primary Products Ingredients Americas LLC, Schaumburg, Illinois.
For further information concerning the conduct of this phase of the
investigations, hearing procedures, and rules of general application,
consult the Commission's Rules of Practice and Procedure, part 201,
subparts A and B (19 CFR part 201), and part 207, subparts A and C (19
CFR part 207).
Although Commerce has preliminarily determined that imports of
citric acid and certain citrate salts from Canada are not being and are
not likely to be sold in the United States at less than fair value, for
purposes of efficiency the Commission hereby waives rule 207.21(b) \1\
so that the final phase of the investigations may proceed concurrently
in the event that Commerce makes a final affirmative determination with
respect to such imports.
---------------------------------------------------------------------------
\1\ Sec. 207.21(b) of the Commission's rules provides that,
where Commerce has issued a negative preliminary determination, the
Commission will publish a Final Phase Notice of Scheduling upon
receipt of an affirmative final determination from Commerce.
---------------------------------------------------------------------------
Participation in the investigations and public service list.--
Persons, including industrial users of the subject merchandise and, if
the merchandise is sold at the retail level, representative consumer
organizations, wishing to participate in the final phase of these
investigations as parties must file an entry of appearance with the
Secretary to the Commission, as provided in Sec. 201.11 of the
Commission's rules, no later than 21 days prior to the hearing date
specified in this notice. A party that filed a notice of appearance
during the preliminary phase of the investigations need not file an
additional notice of appearance during this final phase. The Secretary
will maintain a public service list containing the names and addresses
of all persons, or their representatives, who are parties to the
investigations.
Please note the Secretary's Office will accept only electronic
filings during this time. Filings must be made through the Commission's
Electronic Document Information System (EDIS, <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>).
No in-person paper-based filings or paper copies of any electronic
filings will be accepted until further notice.
Limited disclosure of business proprietary information (BPI) under
an administrative protective order (APO) and BPI service list.--
Pursuant to Sec. 207.7(a) of the Commission's rules, the Secretary
will make BPI gathered in the final phase of these investigations
available to authorized applicants under the APO issued in the
investigations, provided that the application is made no later than 21
days prior to the hearing date specified in this notice. Authorized
applicants must represent interested parties, as defined by 19 U.S.C.
1677(9), who are parties to the investigations. A party granted access
to BPI in the preliminary phase of the investigations need not reapply
for such access. A separate service list will be maintained by the
Secretary for those parties authorized to receive BPI under the APO.
Staff report.--The prehearing staff report in the final phase of
these investigations will be placed in the nonpublic record on December
28, 2026, and a public version will be issued thereafter, pursuant to
Sec. 207.22 of the Commission's rules.
Hearing.--The Commission will hold a hearing in connection with the
final phase of this investigation beginning at 9:30 a.m. on January 12,
2027. Requests to appear at the hearing should be filed in writing with
the Secretary to the Commission on or before January 6, 2027. Any
requests to appear as a witness via videoconference must be included
with your request to appear. Requests to appear via videoconference
must include a statement explaining why the witness cannot appear in
person; the Chairman, or other person designated to conduct the
investigation, may in their discretion for good cause shown, grant such
a request. Requests to appear as remote witness due to illness or a
positive COVID-19 test result may be submitted by 3:00 p.m. the
business day prior to the hearing. Further information about
participation in the hearing will be posted on the Commission's website
at <a href="https://www.usitc.gov/calendarpad/calendar.html">https://www.usitc.gov/calendarpad/calendar.html</a>.
A nonparty who has testimony that may aid the Commission's
deliberations may request permission to present a short statement at
the hearing. All parties and nonparties desiring to appear at the
hearing and make oral presentations should attend a prehearing
conference, if deemed necessary, to be held at 9:30 a.m. on January 8,
2026. Parties shall file and serve written testimony and presentation
slides in connection with their presentation at the hearing by no later
than noon on January 11, 2027. Oral testimony and written materials to
be submitted at the public hearing are governed by sections
201.6(b)(2), 201.13(f), and 207.24 of the Commission's rules. Parties
must submit any request to present a portion of their hearing testimony
in camera no later than 7 business days prior to the date of the
hearing.
Written submissions.--Each party who is an interested party shall
submit a prehearing brief to the Commission. Prehearing briefs must
conform with the provisions of Sec. 207.23 of the Commission's rules;
the deadline for filing is 5:15 p.m. on January 5, 2027. Parties shall
also file written testimony in connection with their presentation at
the hearing, and posthearing briefs, which must conform with the
provisions of Sec. 207.25 of the Commission's rules. The deadline for
filing posthearing briefs is 5:15 p.m. on January 20, 2027. In
addition, any person who has not entered an appearance as a party to
the investigations may submit a written statement of information
pertinent to the subject of the investigations, including statements of
support or opposition to the petition, on or before 5:15 p.m. on
January 20, 2027. On February 2, 2027, the Commission will make
available to parties all information on which they have not had an
opportunity to comment. Parties may submit final comments on this
information on or before 5:15 p.m. on February 4, 2027, but such final
comments must not contain new factual information and must otherwise
comply with Sec. 207.30 of the Commission's rules. All written
submissions must conform with the provisions of Sec. 201.8 of the
Commission's rules; any submissions that contain BPI must also conform
with the requirements of Sec. Sec. 201.6, 207.3, and 207.7 of the
Commission's rules. The Commission's Handbook on Filing Procedures,
available on the Commission's website at https://www.usitc.gov/
documents/
[[Page 57922]]
handbook_on_filing_procedures.pdf, elaborates upon the Commission's
procedures with respect to filings.
Additional written submissions to the Commission, including
requests pursuant to Sec. 201.12 of the Commission's rules, shall not
be accepted unless good cause is shown for accepting such submissions,
or unless the submission is pursuant to a specific request by a
Commissioner or Commission staff.
In accordance with Sec. Sec. 201.16(c) and 207.3 of the
Commission's rules, each document filed by a party to the
investigations must be served on all other parties to the
investigations (as identified by either the public or BPI service
list), and a certificate of service must be timely filed. The Secretary
will not accept a document for filing without a certificate of service.
Authority: These investigations are being conducted under authority
of title VII of the Tariff Act of 1930; this notice is published
pursuant to Sec. 207.21 of the Commission's rules.
By order of the Commission.
Issued: September 9, 2026.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2026-18586 Filed 9-10-26; 8:45 am]
BILLING CODE 7020-02-P
</pre></body>
</html>Indexed from Federal Register on September 11, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.